Serologic evidence of toxoplasmosis among patients with polymyositis.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D003168:Complement Fixation Tests; D003429:Cross Reactions; D003882:Dermatomyositis / Q000150:complications / Q000276:immunology; D006801:Humans; D008875:Middle Aged; D009132:Muscles / Q000276:immunology; D009135:Muscular Diseases / Q000150:complications / Q000276:immunology; D009220:Myositis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D011739:Pyrimethamine / Q000627:therapeutic use; D012698:Serologic Tests; D013449:Sulfonamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000150:complications* / Q000276:immunology / Q000382:microbiology
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D013449:Sulfonamides; D011739:Pyrimethamine